SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?

Size: px
Start display at page:

Download "SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?"

Transcription

1 SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria

2 Disclosures DISCLOSURE STATEMENT OF FINANCIAL INTEREST Kurt Huber, MD, FESC, FACC Research Grants from Bristol-Myers Squibb, Eli Lilly, Medtronic, Sanofi-Aventis Consulting Fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Fibrex, Eli Lilly, Portola, Sanofi-Aventis, Schering-Plough, and The Medicines Company Lecture Fees from AstraZeneca, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cordis / Johnson&Johnson, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Pfizer, Sanofi- Aventis, and The Medicines Company

3 STEMI (all comers, all treatment): In-hospital mortality Vienna Mortality (%) % TT CCU/ICU 17% Formation of network 2013 TT was only offered to <3% of STEMI patients % 8.7% 7.6% 7.2% 5.2% Any reperfusion Data partially based on Kalla et al. Circulation 2006;113: ; & Lanschuetzer et al. Unpublished. TT, thrombolytic therapy; CCU, coronary care unit; ICU, intensive care unit; STEMI, ST-elevation myocardial infarction

4 Case report: 66-year-old female Ongoing chest pain for 1 hour Called 144 (Vienna STEMI network), was seen by an emergency physician (ambulance) within 15 min Risk factors: Hypertension, DM-Type 2 (NIDDM) History of TIA 2 years ago Recent medication: Beta-blocker, Aspirin, Glucophage STEMI, ST-elevation myocardial infarction; DM, diabetes mellitus; NIDDM, non-insulin dependent diabetes mellitus; TIA, transient ischaemic attack

5 ECG in the ambulance I V II V III V avr V V avl V avf

6 Q1: What to do? (FMC to balloon is 80 min on average in Vienna) 1. Pre-hospital fibrinolytic therapy UFH, aspirin IV, clopidogrel, TNK-tPA 2. Pre-hospital therapy and rush to the cath lab UFH, aspirin IV, P2Y12-inhibitor 3. Rush to the cath lab without pre-treatment FMC, first medical contact; IV, intravenous; TNK-tPA, tenecteplase-tissue plasminogen activator; UFH, unfractionated heparin

7 Organisation of STEMI patient disposal describing pre- and in-hospital management, and reperfusion strategies within 12 h of FMC EMS Pre-hospital diagnosis & care Ambulance to Cath Lab Primary PCI capable centre Primary PCI Rescue PCI Symptoms of STEMI GP / Cardiologist Immediate transfer to Cath Lab Self referral Private transportation Non-primary PCI capable centre PCI possible <2h yes no no yes Successful fibrinolysis? Transfer to ICU of PCI-capable centre Immediate fibrinolysis Coronary angiography 3 to 24 h after FMC Delayed PCI as required Steg et al. Eur Heart J 2012;33: EMS, emergency medical services; GP, general practitioner; PCI, percutaneous coronary intervention; FMC, first medical contact; ICU, intensive care unit; STEMI, ST-elevation myocardial infarction

8 We decided Pre-hospital fibrinolytic therapy UFH, aspirin IV, clopidogrel, TNK-tPA Pre-hospital therapy plus rush to the cath lab UFH, aspirin IV, clopidogrel Rush to the cath lab without pre-treatment However, due to unexpected traffic jam, transfer to the hospital was prolonged and time from FMC to PPCI was 160 minutes!

9 Coronary angiography The patient survived but LVEF after successful PPCI was only 36%

10 Logistics for networks ESC STEMI guidelines Table 8. Logistics of pre-hospital care Recommendations Class a Level b Ref c Ambulance teams must be trained and equipped to identify STEMI (with use of ECG recorders and telemetry as necessary) and administer initial therapy, including thrombolysis where applicable. The prehospital management of STEMI patients must be based on regional networks designed to deliver reperfusion therapy expeditiously and effectively, with efforts made to make primary PCI available to as many patients as possible. Primary PCI-capable centres must deliver a 24/7 service, be able to start primary PCI as soon as possible and within 60 min from the initial call. I B (43) I B (47) I B (6,52,55) Steg et al. Eur Heart J 2012;33: ECG, electrocardiogram; STEMI, ST-elevation myocardial infarction; PCI, percutaneous coronary intervention

11 FAST-MI 2005: early mortality according to reperfusion therapy % None PHT PPCI IHT 5-day 30-day Danchin et al. Circulation 2008;118: PHT, pre-hospital thrombolysis; IHT, in-hospital thrombolysis; PPCI, primary percutaneous coronary intervention

12 Vienna STEMI registry Reperfusion strategies, time delay and mortality Pain-to-first contact <120 min Inhospital mortality p= <60 min (n=190) min (n=265) tt (n=357) p=0.013 p= min (n=106) 17.6 >180 min (n=51) 74.3% of STEMI patients referred for PPCI were treated <120 min Landsteiner et al. 2010; unpublished. However 8.3% of STEMI patients referred for PPCI received first balloon inflation >3 h later TT, thrombolytic therapy; PPCI, primary percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction

13 Vienna STEMI network ( ) FMC-to-PPCI time intervals TT recommended, if FMC-to-PPCI expected to exceed 90 min Patient 60% 20% 20% min 144* Self PCI Self non-pci min min 30 min 144* min FMC-to-PPCI: min *144 = emergency medical services number, Austria FMC = DG by 12-lead ECG Landsteiner et al. 2010; unpublished. PPCI FMC-to-PPCI in self-comers to a non-pci centre: min TT, thrombolytic therapy; FMC, first medical contact; PPCI, primary percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction

14 Cardiac mortality: STREAM trial 15 Cuumulative incidence (%) Gray s Test p= p=0.927 RR 0.98 ( ) PPCI 4.1% TNK 4.0% Number at risk Months since randomisation TNK PPCI Sinnaeve et al. Presented at AHA 2013; Accepted for publication in Circulation 09/2014. PPCI, primary percutaneous coronary intervention; TNK, tenecteplase; RR, relative risk

15 Kaplan-Meier curves for primary endpoint 20 Probability of all-cause death/shock/chf/remi (%) Primary PCI 14.3% Tenecteplase 12.4% p= Days since randomisation Number at risk Tenecteplase Primary PCI Adapted from Armstrong et al. N Engl J Med 2013;368: PCI, percutaneous coronary intervention; CHF, congestive heart failure; remi, subsequent myocardial infarction

16 Danish registry Impact of time delay FMC-to-PCI on long-term mortality p<0.01 FMC to PCI Median FU: 3.4 years ( years) (2092) (275) 25 (2643) % Mortality (43) Time delay (minutes) Terkelsen et al. JAMA 2010;304: FMC, first medical contact; FU, follow-up; PCI, percutaneous coronary intervention

17 SUMMARY Keep pre-hospital thrombolysis in your network for patients with short onset of pain and a low risk of intracerebral bleeding in whom FMC to balloon is expected to be prolonged (Vienna 2014: anterior wall MI, <75 years, onset of pain <3 h; <3% of all STEMIs) FMC, first medical contact; MI, myocardial infarction; STEMI, STelevation myocardial infarction

18

Antithrombotic therapy in the ACS patient with atrial fibrillation

Antithrombotic therapy in the ACS patient with atrial fibrillation Antithrombotic therapy in the ACS patient with atrial fibrillation Kurt Huber, MD, FESC, FACC, FAHA 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Great Minds,

More information

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications

More information

A Patient with Chest Pain and Atrial Fibrillation

A Patient with Chest Pain and Atrial Fibrillation A Patient with Chest Pain and Atrial Fibrillation Kurt Huber, Vienna, Austria Declaration of Interest Lecturing & Consulting Activities: AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi

More information

The Strategic Reperfusion Early After STEMI study Implications for clinical practice

The Strategic Reperfusion Early After STEMI study Implications for clinical practice The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional

More information

Decision for fibrinolysis or primary PCI in the prehospital phase

Decision for fibrinolysis or primary PCI in the prehospital phase Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,

More information

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION PCI Hospital Ambulance/ER STREAM design STEMI

More information

STEMI Care 2014 at the Crossroads: Taking the right road

STEMI Care 2014 at the Crossroads: Taking the right road STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,

More information

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants

More information

New Insights on Reperfusion Choices Implications of STREAM. Paul W Armstrong MD

New Insights on Reperfusion Choices Implications of STREAM. Paul W Armstrong MD New Insights on Reperfusion Choices Implications of STREAM ESC STEMI Satellite Symposium August 31 2014 Aligning Optimal Care to Time Place and Person Paul W Armstrong MD Disclosure Statement Paul W. Armstrong

More information

Pharmaco-Invasive Approach for STEMI

Pharmaco-Invasive Approach for STEMI Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),

More information

The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why.

The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why. Implementing the pharmacoinvasive strategy in STEMI The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why. 7:20-7:40 Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Director,

More information

Treatment of ST-elevation myocardial infarction in China: Where are we?

Treatment of ST-elevation myocardial infarction in China: Where are we? Treatment of ST-elevation myocardial infarction in China: Where are we? Associate Professor, Yihong Sun, MD Peking University People s Hospital Beijing, China Disclosure conflict of Interest The Challenges

More information

Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology

Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology UNIVERSITY OF AARHUS 1 COI Speakers fee: Aspen, AZ, Bayer, BMS/Pfizer Departmental research grant:

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,

More information

PHARMACO-INVASIVE STRATEGY COMPARED WITH PPCI: DESIGN AND MAIN OUTCOMES OF THE STREAM TRIAL

PHARMACO-INVASIVE STRATEGY COMPARED WITH PPCI: DESIGN AND MAIN OUTCOMES OF THE STREAM TRIAL PHARMACO-INVASIVE STRATEGY COMPARED WITH PPCI: DESIGN AND MAIN OUTCOMES OF THE STREAM TRIAL Frans Van de Werf Leuven, Belgium Disclosures Study grant from Boehringer Ingelheim to perform the STREAM trial,

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST How to manage antiplatelet treatment in patients with diabetes in acute coronary syndrome Lars Wallentin Professor of Cardiology, Chief Researcher Cardiovascular Science

More information

Dashboard and Outcomes Report with Case Studies

Dashboard and Outcomes Report with Case Studies Dashboard and Outcomes Report with Case Studies Kim Hustler Clinical Quality Consultant, American College of Cardiology The following relationships exist: Kim Hustler: No Disclosures Section F- Procedures

More information

Frans Van de Werf, MD, PhD Leuven, Belgium

Frans Van de Werf, MD, PhD Leuven, Belgium STEMI Cases and the ESC STEMI Guidelines Frans Van de Werf, MD, PhD Leuven, Belgium The Easy Case 2/21/2011 History and Risk Factors 50-year old male patient Past medical history: Teratoma right testis

More information

Update Guidelines in STEMI Management: Focus on Logistic and System Approach to Reperfusion Therapy

Update Guidelines in STEMI Management: Focus on Logistic and System Approach to Reperfusion Therapy March 14 th, 2018 The First Asia Forum in Emergency Medicine BNH Hospital, Bangkok, Thailand Update Guidelines in STEMI Management: Focus on Logistic and System Approach to Reperfusion Therapy Wacin Buddhari,

More information

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck. DECLARATION OF CONFLICT OF INTEREST Lecture fees: AstraZeneca, Ely Lilly, Merck. Risk of stopping dual therapy. S D Kristensen, FESC Aarhus Denmark Acute coronary syndrome: coronary thrombus Platelets

More information

Primary Percutaneous Coronary Intervention

Primary Percutaneous Coronary Intervention The big 5 in PCI Primary Percutaneous Coronary Intervention W. Wijns (Aalst, BE) Disclosures Consulting Fees: on my behalf go to the Cardiovascular Research Center Aalst Contracted Research between the

More information

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD

Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD Disclosures Research contracts: AstraZeneca, Bayer, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, The Medicines Company,

More information

Impact of CYP2C19 and ABCB1 SNPs on outcomes with ticagrelor versus clopidogrel in acute coronary syndromes: a PLATO genetic substudy

Impact of CYP2C19 and ABCB1 SNPs on outcomes with ticagrelor versus clopidogrel in acute coronary syndromes: a PLATO genetic substudy Impact of CYP2C19 and ABCB1 SNPs on outcomes with ticagrelor versus clopidogrel in acute coronary syndromes: a PLATO genetic substudy Lars Wallentin, Stefan James, Robert F Storey, Martin Armstrong, Bryan

More information

Downloaded from:

Downloaded from: Annemans, L; Danchin, N; Van de Werf, F; Pocock, S; Licour, M; Medina, J; Bueno, H (2016) Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis

More information

P2Y 12 blockade. To load or not to load before the cath lab?

P2Y 12 blockade. To load or not to load before the cath lab? UPDATE ON ANTITHROMBOTICS IN ACUTE CORONARY SYNDROMES P2Y 12 blockade. To load or not to load before the cath lab? Franz-Josef Neumann Personal: None Institutional: Conflict of Interest Speaker honoraria,

More information

STEMI Linee guida ESC Maddalena Lettino, Italy

STEMI Linee guida ESC Maddalena Lettino, Italy STEMI Linee guida ESC 2017 Maddalena Lettino, Italy Disclosure Speaker fee: Aspen, Astra Zeneca, BMS, Boehringer, Eli Lilly, DaichiiSankio, Bayer, Pfizer, Sanofi Advisory board member: Astra Zeneca, Eli

More information

I have no financial relationships to disclose

I have no financial relationships to disclose I have no financial relationships to disclose Networking decreases mortality Vasil Velchev,MD,PhD UH St. Anna Sofia time = myocardium = life Transfer for angioplasty vs. Immediate Thrombolysis (hospital

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis

More information

ST-elevation myocardial infarctions (STEMIs)

ST-elevation myocardial infarctions (STEMIs) Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve

More information

Stable CAD, Elective Stenting and AFib

Stable CAD, Elective Stenting and AFib Stable CAD, Elective Stenting and AFib Kurt Huber, MD, FESC, FACC, FAHA 3 rd Medical Department Cardiology & Intensive Care Medicine Wilhelminenhospital & Sigmund Freud Private University, Medical School

More information

STEMI Presentation and Case Discussion. Case #1

STEMI Presentation and Case Discussion. Case #1 STEMI Presentation and Case Discussion Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando, Florida September 17 th,

More information

Improving the Outcomes of

Improving the Outcomes of Improving the Outcomes of STEMI Shelley Valaire, ACP; and Robert Welsh, MD, FRCPC Presented at the University of Alberta s 6th Annual Cardiology Update for General Practitioners and Internists, Edmonton,

More information

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.

More information

Antithrombotic Therapy in ACS Pretreatment in STEMI. Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany

Antithrombotic Therapy in ACS Pretreatment in STEMI. Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany Antithrombotic Therapy in ACS Pretreatment in STEMI Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany Potential conflicts of interest Speaker s name: Christian W. Hamm I have the following

More information

Optimal antithrombotic therapy:

Optimal antithrombotic therapy: Optimal antithrombotic therapy: upstream and during primary PCI. Steen D Kristensen, MD, DMSc, FESC Professor and Consultant Interventional Cardiologist Aarhus University, Denmark UNIVERSITY OF AARHUS

More information

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927

More information

DISCUSSION QUESTION - 1

DISCUSSION QUESTION - 1 CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure

More information

Daily practice of ACS management in the Gulf: Data from Gulf COAST

Daily practice of ACS management in the Gulf: Data from Gulf COAST Daily practice of ACS management in the Gulf: Data from Gulf COAST Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Head, Division of Cardiology Mubarak Alkabeer Hospital

More information

Controversies on Primary angioplasty in STEMI

Controversies on Primary angioplasty in STEMI Controversies on Primary angioplasty in STEMI 원주의대이승환 Case ( 51/M) CC C.C: ongoing squeezing chest pain D : for 2 hours Risk factors Current smoker ( 40 PYs) Hypercholesterolemia (+) Case ( 51/M) Physical

More information

Literature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction

Literature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction Literature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction EMS Bureau Protocol Review Steering Committee Background In 2009, approximately 683,000 Americans

More information

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo,

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo, Stent For Life, Egypt A Success Story Hany Ragy MD, FSCAI NHI, Cairo, Egypt @hragy Stent For Life Initiative in Egypt Professor Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology Department, Alexandria

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

The Role of Enoxaparin Across ACS Spectrum

The Role of Enoxaparin Across ACS Spectrum SYP.ENO.16.08.01 The Role of Enoxaparin Across ACS Spectrum dr. Hariadi Hariawan, Sp.PD, Sp.JP (K) TOPICS Optimum Anticoagulation in ACS patients : Summary from Guidelines Role of Enoxaparin in ACS Spectrum

More information

Acute coronary syndromes A European viewpoint. Felicita Andreotti, MD PhD FESC Catholic University Hospital Cardiovascular Diseases - Rome, IT

Acute coronary syndromes A European viewpoint. Felicita Andreotti, MD PhD FESC Catholic University Hospital Cardiovascular Diseases - Rome, IT Acute coronary syndromes A European viewpoint Felicita Andreotti, MD PhD FESC Catholic University Hospital Cardiovascular Diseases - Rome, IT Potential conflicts of interest In the past 2 years Felicita

More information

Patient and System Time Delay

Patient and System Time Delay Quality Indicators in the Management of ST-elevation Myocardial Infarction Patient and System Time Delay Jacob Thorsted Sorensen, MD, PhD Department of Cardiology Aarhus University Hospital, Denmark Disclosures

More information

Oral anticoagulation/antiplatelet therapy in the secondary prevention of ACS patients the cost of reducing death!

Oral anticoagulation/antiplatelet therapy in the secondary prevention of ACS patients the cost of reducing death! Oral anticoagulation/antiplatelet therapy in the secondary prevention of ACS patients the cost of reducing death! Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization

More information

Rural Minnesota STEMI Systems of Care

Rural Minnesota STEMI Systems of Care CARDIOVASCULAR HEALTH UNIT Rural Minnesota STEMI Systems of Care Almost 250,000 Americans experience ST-elevation Myocardial Infarction (STEMI), the deadliest form of heart attack, each year. Of approximately

More information

7 th Munich Vascular Conference

7 th Munich Vascular Conference 7 th Munich Vascular Conference Secondary prevention of major cardiovascular events in patients with CHD or PAD - What can we learn from EUCLID and COMPASS, evaluating Clopidogrel, Ticagrelor and Univ.-Prof.

More information

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction Developed in Collaboration with American College of Emergency Physicians and Society for Cardiovascular Angiography and

More information

Chapter 3 for 12 Lead Training -Precourse-

Chapter 3 for 12 Lead Training -Precourse- ONTARIO BASE HOSPITAL GROUP Chapter 3 for 12 Lead Training -Precourse- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE ONTARIO BASE HOSPITAL GROUP Introduction and Purpose Introduction

More information

STEMI 2014 YAHYA KIWAN. Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital

STEMI 2014 YAHYA KIWAN. Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital STEMI 2014 YAHYA KIWAN Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital Aspiration Thrombectomy Manual aspiration thrombectomy is reasonable for patients undergoing primary PCI. I

More information

Disclosures. Dr. Scirica has also served as a consultant for Lexicon, Arena, Gilead, and Eisai.

Disclosures. Dr. Scirica has also served as a consultant for Lexicon, Arena, Gilead, and Eisai. Disclosures Benjamin M. Scirica, MD, MPH, is employed by the TIMI Study Group, which has received research grants from Abbott, AstraZeneca, Amgen, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb,

More information

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner

More information

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure

More information

On admission Acute extensive anterior STEMI

On admission Acute extensive anterior STEMI Mr B 52 years old male Smoker No prior known CAD Presents with 1 hour intermittent crushing retrosternal chest pain Transferred by MICU directly to CCU (ASA, Heparin) On admission Intense pain, diaphoretic

More information

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden

More information

Early release, published at on April 30, Subject to revision.

Early release, published at  on April 30, Subject to revision. CMAJ Early release, published at www.cmaj.ca on April 30, 2012. Subject to revision. Research Baseline as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial Hany

More information

Management of Acute Myocardial Infarction

Management of Acute Myocardial Infarction Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care

More information

Acute Coronary Syndrome (ACS) is the consequence of

Acute Coronary Syndrome (ACS) is the consequence of Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok

More information

Original Investigation

Original Investigation Research Original Investigation Fibrinolysis Use Among Patients Requiring Interhospital Transfer for ST-Segment Elevation Myocardial Infarction Care A Report From the US National Cardiovascular Data Registry

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

The role of pre hospital thrombolysis. Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel

The role of pre hospital thrombolysis. Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel The role of pre hospital thrombolysis Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel Is thrombolysis still valid? Disclosure I am an Interventional Cardiologist STEMI is mainly a thrombotic

More information

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not

More information

Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot

Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot Agrément FMC N 100 437 Popul. millions Area km2 Density inha/km2

More information

Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction

Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction JACC: CARDIOVASCULAR INTERVENTIONS VOL. 3, NO. 11, 2010 2010 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2010.08.015 CLINICAL RESEARCH

More information

Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease

Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease CHRISTOPHER B. GRANGER, MD Professor of Medicine Division of Cardiology, Department of Medicine; Director, Cardiac Care Unit Duke University Medical Center, Durham, NC Clinical and Economic Value of Rivaroxaban

More information

The Swedish model of STEMI treatment. Professor Eva Swahn

The Swedish model of STEMI treatment. Professor Eva Swahn The Swedish model of STEMI treatment Professor Eva Swahn Linköping! Single centre model One hospital started (1995) Special education for all; ambulance staff, ER, CCU, doctors ECG by mobile Fax to Cardiologist

More information

Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction

Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology Vol. 61, No. 18, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.066

More information

Intraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention

Intraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention Journal of the American College of Cardiology Vol. 57, No. 19, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.061

More information

Subsequent management and therapies

Subsequent management and therapies ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY

More information

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The

More information

The Burden & Management of Ischaemic Heart Disease in Kenya

The Burden & Management of Ischaemic Heart Disease in Kenya The Burden & Management of Ischaemic Heart Disease in Kenya Dr Harun A Otieno FACC Tuesday, October 6th: Session X PASCAR & CSM Joint Congress 2015, Mauritius Disclosures With regards to this presentation,

More information

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Learning Objectives Learn to recognize the high risk patient Discuss effective management of a high risk NSTEMI patient Review CCS

More information

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Prof. Marco Roffi Geneva University Hospitals Geneva, Switzerland Declaration of interests:

More information

Characteristics of Transient ST-Elevation versus ST-Elevation and Non-ST-Elevation Myocardial Infarction

Characteristics of Transient ST-Elevation versus ST-Elevation and Non-ST-Elevation Myocardial Infarction Characteristics of Transient ST-Elevation versus ST-Elevation and Non-ST-Elevation Myocardial Infarction Blondheim DS, Shochat M, Asif A, Kazatsker M, Frimerman A, Vassilenko L, Abu Fane R, Neiman E, Barel

More information

A Clinical Context Report

A Clinical Context Report Stroke Prevention in Atrial Fibrillation An Expert Commentary With Kenneth W. Mahaffey, MD A Clinical Context Report Stroke Prevention in Atrial Fibrillation Expert Commentary Jointly Sponsored by: and

More information

The optimum reperfusion pathway for ST elevation acute myocardial infarction: development of a decision framework

The optimum reperfusion pathway for ST elevation acute myocardial infarction: development of a decision framework 52 PREHOSPITAL CARE The optimum reperfusion pathway for ST elevation acute myocardial infarction: development of a decision framework J Kendall... There is currently much debate about the relative roles

More information

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI

More information

S. CHASSAING4 P. DEQUENNE5

S. CHASSAING4 P. DEQUENNE5 #10899 - OP013 Importance of delay for management of STEMI: does the helicopter HEMS is better than ground transport with MICU ambulance? Analyze of the French region Centre Registry of Acute Coronary

More information

Mode of admission and its effect on quality indicators in Belgian STEMI patients

Mode of admission and its effect on quality indicators in Belgian STEMI patients 2015 Mode of admission and its effect on quality indicators in Belgian STEMI patients Prof dr M Claeys National Coordinator STEMI registry 29-6-2015 Background The current guidelines for the management

More information

The following is a transcript from a multimedia activity. Interactivity applies only when viewing the activity online.

The following is a transcript from a multimedia activity. Interactivity applies only when viewing the activity online. Presentation 1 The following is a transcript from a multimedia activity. Interactivity applies only when viewing the activity online. This activity is supported by an educational grant from Daiichi Sankyo

More information

Thrombolysis in Acute Myocardial Infarction

Thrombolysis in Acute Myocardial Infarction CHAPTER 70 Thrombolysis in Acute Myocardial Infarction J. S. Hiremath Introduction Reperfusion of the occluded coronary artery at the earliest is the most important aim of management of STEMI. Once a flow

More information

Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCI

Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCI Review Article 945 Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCI Davide Capodanno 1,2 ; Dominick J. Angiolillo 2 1 Ferrarotto

More information

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work. Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary

More information

2010 ACLS Guidelines. Primary goals of therapy for patients

2010 ACLS Guidelines. Primary goals of therapy for patients 2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in

More information

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION?

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? Doron Zahger, MD Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion

More information

County of Santa Clara Emergency Medical Services System

County of Santa Clara Emergency Medical Services System POLICY # 408 County of Santa Clara Emergency Medical Services System Policy #408: STEMI Receiving Center Standards STEMI RECEIVING CENTER STANDARDS Effective: September 1, 2009 Replaces: New Review: November,

More information

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention DA Jones, J Howard, S Gallagher, KS Rathod, A Jain, S Mohiddin, C Knight, A Mathur, EJ

More information

ACC Rockies New Role For An Old Friend: Contemporary Insights From The ECG

ACC Rockies New Role For An Old Friend: Contemporary Insights From The ECG ACC Rockies 2012 New Role For An Old Friend: Contemporary Insights From The ECG Paul W. Armstrong, MD Monday March 12 2012 2012 Disclosure Statement Paul W. Armstrong MD Details available @ http://www.vigour.ualberta.ca

More information

Myocardial Infarction In Dr.Yahya Kiwan

Myocardial Infarction In Dr.Yahya Kiwan Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting

More information

Roule et al. Critical Care (2016) 20:359 DOI /s z

Roule et al. Critical Care (2016) 20:359 DOI /s z Roule et al. Critical Care (2016) 20:359 DOI 10.1186/s13054-016-1530-z RESEARCH Open Access Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction:

More information

Methods Individual patient data from CAPTIM (n = 840, ) and the more recent WEST trial (n = 328, ) were pooled.

Methods Individual patient data from CAPTIM (n = 840, ) and the more recent WEST trial (n = 328, ) were pooled. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous

More information

Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study)

Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study) 30 Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study) RK Singh 1, A Trailokya 2, MM Naik 3 Original Article Abstract Background: ST elevated myocardial infarction

More information

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 May 2011 1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 Yes b) If confirmed please provide details on the number of

More information

Level One STEMI Connecting the Dots changing Points of Care into Systems of Care

Level One STEMI Connecting the Dots changing Points of Care into Systems of Care Level One STEMI Connecting the Dots changing Points of Care into Systems of Care Myron Bloom MD MMM Medical Director Rural Healthcare Quality Network RHQN.org drmbloom@msn.com The Eastern Washington Level

More information